Page last updated: 2024-08-21

cyclopentane and carfilzomib

cyclopentane has been researched along with carfilzomib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ehrenschwender, M; El-Mesery, M; Leich, E; Rauert-Wunderlich, H; Rosenthal, T; Schlosser, A; Schreder, M; Siegmund, D; Stühmer, T; Wajant, H1
Huibregtse, JM; Matouschek, A; Tomita, T1

Other Studies

2 other study(ies) available for cyclopentane and carfilzomib

ArticleYear
The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1
    Cell death & disease, 2019, 08-13, Volume: 10, Issue:8

    Topics: Adult; Aged; Apoptosis; Bortezomib; Cell Line, Tumor; Cell Survival; Cyclopentanes; Female; Humans; Male; Middle Aged; Multiple Myeloma; Necrosis; NF-kappa B; Oligopeptides; Pyrimidines; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Tumor Necrosis Factor-alpha; Ubiquitin-Activating Enzymes

2019
A masked initiation region in retinoblastoma protein regulates its proteasomal degradation.
    Nature communications, 2020, 04-24, Volume: 11, Issue:1

    Topics: Acrylates; Calpain; Cell Cycle; Cell Transformation, Neoplastic; Cyclopentanes; E2F Transcription Factors; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Human papillomavirus 16; Humans; NEDD8 Protein; Oligopeptides; Papillomavirus E7 Proteins; Proteasome Endopeptidase Complex; Protein Stability; Pyrimidines; Recombinant Proteins; Retinoblastoma Binding Proteins; Ubiquitin-Protein Ligases; Ubiquitination; Uterine Cervical Neoplasms

2020